An indictment filed in the US District Court in Montana charged Canada Drugs and affiliates in the UK and Barbados with smuggling, money laundering and conspiracy. The online pharmacy sold $78 million worth of unapproved, mislabeled and in some cases, counterfeit cancer drugs to doctors in the US over a three-year period. All but one of the 14 companies and individuals named as defendants are located outside of the US and will force prosecutors to undertake the extradition process.
